Fulgent Genetics
FLGT
215 hedge funds and large institutions have $422M invested in Fulgent Genetics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 73 increasing their positions, 66 reducing their positions, and 27 closing their positions.
32% more call options, than puts
Call options by funds: $6.78M | Put options by funds: $5.15M
15% more capital invested
Capital invested by funds: $367M → $422M (+$54.8M)
11% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 66
1.19% more ownership
Funds ownership: 44.62% → 45.8% (+1.2%)
4% less funds holding
Funds holding: 224 → 215 (-9)
22% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$11.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$7.75M |
| 3 |
BlackRock
New York
|
+$3.82M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.52M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
-$17.4M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$4.04M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.56M |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$1.36M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$1.26M |
FLGT Hedge Fund Activity: Q1 2023 in Review
215 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2023, worth a combined $422M — up 15% from $367M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of FLGT and 21 opened new positions — a net loss of 6 holders — while 66 trimmed existing stakes and 73 added.
The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $11.8M. The largest seller was Pacer Advisors, exiting entirely with an estimated $17.4M sold.
- 215 institutional investors held Fulgent Genetics (FLGT) as of Q1 2023, down from 224 in Q4 2022.
- Funds reported $422M of Fulgent Genetics stock for Q1 2023, up 15% quarter-over-quarter.
- 21 funds opened new Fulgent Genetics positions in Q1 2023 and 27 closed out, a net change of -6 holders.
- The largest Fulgent Genetics buyer in Q1 2023 was Divisadero Street Capital Management, an estimated $11.8M added.
- The largest Fulgent Genetics seller in Q1 2023 was Pacer Advisors, an estimated $17.4M sold.
Based on aggregated 13F filings for Q1 2023.